Company Filing History:
1 out of 17 
1 out of 1 Years Active: 2011
Title: Stefania Tacconelli: Innovator in Pharmaceutical Chemistry
Introduction
Stefania Tacconelli is a prominent inventor based in Chieti, Italy. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical applications. Her work focuses on the design and synthesis of isoxazole derivatives that have potential therapeutic benefits.
Latest Patents
Stefania Tacconelli holds a patent for "Functionalized diarylisoxazoles inhibitors of ciclooxygenase." This patent includes isoxazole derivatives, specifically diarylisoxazole derivatives that inhibit cyclooxygenase (COX), particularly cyclooxygenase-1 (COX-1). The patent outlines their pharmaceutical compositions, the processes for their preparation, and their applications in chemoprevention and treatment of inflammatory syndromes. Additionally, these compounds are relevant in the prevention and treatment of various carcinomas, including intestinal, ovarian, and cutaneous carcinomas. They also have applications in managing pain syndromes, especially post-surgery, and in the cardiovascular field as antithrombotics, vasoprotectives, and cardioprotectives. She has 1 patent to her name.
Career Highlights
Throughout her career, Stefania has worked at esteemed institutions such as Università degli Studi di Bari and Università degli Studi “G. D'Annunzio” in Chieti. Her academic and research endeavors have significantly advanced the understanding of cyclooxygenase inhibitors and their therapeutic potential.
Collaborations
Stefania has collaborated with notable colleagues, including Antonio Scilimati and Paola Vitale. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation in pharmaceutical chemistry.
Conclusion
Stefania Tacconelli is a distinguished inventor whose work in pharmaceutical chemistry has the potential to impact the treatment of various medical conditions. Her innovative research continues to pave the way for advancements in drug development and therapeutic applications.